Tweet Archive for April 2020 « page 15
@drajay1 @TheJEADV Here it is
Cutaneous manifestations in COVID‐19: a first perspective
onlinelibrary.wiley.com/doi/10.1111/jd…
an…
https://twitter.com/i/web/status/1247470553914621952
RT @juleslipoff: Our paper in @JAADjournals guiding dermatologists and all providers how to implement #telehealth in your clinics fast in a…
RT @juleslipoff: New interview in @DermTimesNow on how telemedicine can help practices thrive during the COVID-19 crisis #telemedicine #COV…
@DermaSanMartin @eadv @TheJEADV @imcascongress @aedv_es @julianconejomir @SergioVanoG @Dr_A_Sadek @dranthonyrossi…
https://twitter.com/i/web/status/1247411916764598272
@DermatologyNews thanks for your post about the webinar
COVID-19 and Clinical Dermatology: what does it change?
April 15th webinar. Dermatologists from 7 countries across…
https://twitter.com/i/web/status/1247394144286396418
RT @ducrest: Adalimumab (THE $20 billion product) and the challenges for biosimilars – is the window closing for #biosimilars to have the l…
RT @ducrest: Addressing Bias in #ArtificialIntelligence in Health Care jamanetwork.com/journals/jama/… via @JAMA_current and about image classifica…
RT @NEJM: #VisualAbstract: Nemolizumab in Moderate-to-Severe Prurigo Nodularis. #Neurology #Dermatology